Public-private collaborations in drug development : boosting innovation or alleviating risk?
Year of publication: |
February 2018
|
---|---|
Authors: | Crispeels, Thomas ; Willems, Jurgen ; Scheerlinck, Ilse |
Published in: |
Public management review. - Abingdon : Taylor & Francis, ISSN 1471-9037, ZDB-ID 2046437-X. - Vol. 20.2018, 2, p. 273-292
|
Subject: | Public–private collaboration | cross-sector collaboration | drug development | trial success | Öffentlich-private Partnerschaft | Public-private partnership | Forschungskooperation | Research collaboration | Pharmaindustrie | Pharmaceutical industry | Innovation | Arzneimittel | Pharmaceuticals | Unternehmenskooperation | Inter-firm cooperation | Pharmakologie | Pharmacology | Produktentwicklung | New product development | Kooperation | Cooperation |
-
Risk-sharing in pharmaceutical R&D collaborations : the case of out-licensing
Reepmeyer, Gerrit, (2005)
-
Patents, Partnerships, and the Pre-Competitive Collaboration Myth in Pharmaceutical Innovation
Vertinsky, Liza, (2015)
-
The rise of spin-offs : fueling pharmaceutical innovation through collaboration
Yashiro, Kentaro, (2024)
- More ...
-
Strategic and innovation networks in the Flanders biotechnology industry
Crispeels, Thomas, (2013)
-
Crispeels, Thomas, (2015)
-
International university-university technology transfer : strategic management framework
De Moortel, Kevin, (2018)
- More ...